The Korea Disease Control Agency (KDCA) has issued a nationwide Japanese Encephalitis (JE) alert after the first detection of the vector mosquito, Culex tritaeniorhynchus, in Jeju Special Self-Governing Province on March 20, 2026. Japanese Encephalitis is a mosquito-borne viral disease prevalent in South Asia and the Western Pacific, with the vector widely distributed across Korea. The KDCA has been monitoring mosquito occurrence and pathogen infection since 1975, and climate change has advanced the appearance of vector mosquitoes, prompting earlier surveillance this year. The policy aims to minimize JE cases through vaccination and comprehensive mosquito control.
The alert impacts children eligible for national immunization, adults in high-risk areas such as rice fields and pig farms, long-term foreign residents from non-endemic regions, and travelers to JE-risk countries. The KDCA recommends strict adherence to vaccination schedules for children born after 2013 and urges adults in risk zones or travelers to receive paid vaccinations. Recent data show an average of 17.4 JE cases annually in Korea, with most cases reported between August and November. Men and individuals aged 50 and above are disproportionately affected, and severe cases can result in neurological complications or death.
Surveillance for vector mosquitoes began one week earlier than last year, starting March 16, 2026, due to higher average temperatures in Jeju. Within two days, 18 mosquitoes were collected, including one vector species. The nationwide alert was officially issued on March 20, 2026. The KDCA outlines criteria for issuing alerts and warnings based on mosquito density, pathogen detection, and patient occurrence. Vaccination schedules are detailed for both inactivated and live vaccines, with specific intervals and age requirements. Local governments are instructed to identify and manage mosquito breeding sites, especially in vulnerable areas.
Frequently asked questions include: What are the symptoms of Japanese Encephalitis? Early symptoms are mild, such as fever and headache, but severe cases can progress to encephalitis, seizures, and paralysis, with a 20–30% mortality rate. Is vaccination effective? Yes, JE vaccines are highly effective and recommended for children and high-risk adults. What prevention measures should be taken? Avoid outdoor activities at night during mosquito season, wear protective clothing, use repellents, and eliminate standing water near homes. The KDCA stresses the importance of following these guidelines to reduce infection risk.
Metaqsol opinion: The KDCA’s earlier surveillance and nationwide alert demonstrate a strong response to the shifting risk profile of Japanese Encephalitis due to climate change. By emphasizing vaccination for children and high-risk adults, and mandating local mosquito control, the policy is well-grounded in epidemiological data. The inclusion of detailed prevention guidelines and targeted recommendations for vulnerable groups supports effective risk reduction. Continued vigilance and adherence to these measures are essential for minimizing JE cases and safeguarding public health.